查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420953

辅助生殖技术市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Assisted Reproductive Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 189 Pages | 商品交期: 2-10个工作天内

价格

辅助生殖技术市场 - 报告范围

TMR 关于全球辅助生殖技术市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球辅助生殖技术的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球辅助生殖技术市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解辅助生殖技术市场。

市场概况
2023年市场价值 259 亿美元
2031 年市场价值 586 亿美元
CAGR 9.4%

该报告深入探讨了全球辅助生殖技术市场的竞争格局。全球辅助生殖技术市场的主要参与者已被确定，并且每个参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球辅助生殖技术市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 关键技术/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依技术分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2017-2031
    • 体外受精
      • 胞浆内单一精子注射 (ICSI)
      • 植入前遗传学诊断（PGD）
    • 人工授精
      • 子宫内人工授精 (IUI)
      • 子宫颈内人工授精 (ICI)
      • 其他的
    • 代孕
    • 其他的
  • 市场吸引力分析：依技术分类

第 7 章：全球市场分析与预测：按程序

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按程序，2017-2031
    • 冷冻供体
    • 冻结非捐赠者
    • 新的捐赠者
    • 新鲜的非捐赠者
    • 胚胎银行
  • 市场吸引力分析：按程序

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 生育诊所
    • 医院
    • 其他的
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Merck KGaA
    • CooperSurgical, Inc.
    • FUJIFILM Irvine Scientific
    • Vitrolife AB
    • Hamilton Thorne, Inc.
    • Nikon Corporation
    • Nidacon International AB
    • Laboratoire CCD
    • Esco Micro Pte. Ltd.
Product Code: TMRGL29234

Assisted Reproductive Technology Market - Scope of Report

TMR's report on the global assisted reproductive technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global assisted reproductive technology market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global assisted reproductive technology market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the assisted reproductive technology market.

Market Snapshot
Market Value in 2023US$ 25.9 Bn
Market Value in 2031US$ 58.6 Bn
CAGR9.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global assisted reproductive technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global assisted reproductive technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global assisted reproductive technology market.

The report delves into the competitive landscape of the global assisted reproductive technology market. Key players operating in the global assisted reproductive technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global assisted reproductive technology market profiled in this report.

Key Questions Answered in Global assisted reproductive technology Market Report:

  • What is the sales/revenue generated by assisted reproductive technology across all regions during the forecast period?
  • What are the opportunities in the global assisted reproductive technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Assisted Reproductive Technology Market - Research Objectives and Research Approach

The comprehensive report on the global assisted reproductive technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global assisted reproductive technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global assisted reproductive technology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Assisted Reproductive Technology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2017-2031
    • 6.3.1. In Vitro Fertilization
      • 6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 6.3.2. Artificial Insemination
      • 6.3.2.1. Intrauterine Insemination (IUI)
      • 6.3.2.2. Intracervical Insemination (ICI)
      • 6.3.2.3. Others
    • 6.3.3. Surrogacy
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Technology

7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Procedure, 2017-2031
    • 7.3.1. Frozen Donor
    • 7.3.2. Frozen Non-donor
    • 7.3.3. Fresh Donor
    • 7.3.4. Fresh Non-donor
    • 7.3.5. Embryo Banking
  • 7.4. Market Attractiveness Analysis, by Procedure

8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Fertility Clinics
    • 8.3.2. Hospitals
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Assisted Reproductive Technology Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Technology, 2017-2031
    • 10.3.1. In Vitro Fertilization
      • 10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 10.3.2. Artificial Insemination
      • 10.3.2.1. Intrauterine Insemination (IUI)
      • 10.3.2.2. Intracervical Insemination (ICI)
      • 10.3.2.3. Others
    • 10.3.3. Surrogacy
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Procedure, 2017-2031
    • 10.4.1. Frozen Donor
    • 10.4.2. Frozen Non-donor
    • 10.4.3. Fresh Donor
    • 10.4.4. Fresh Non-donor
    • 10.4.5. Embryo Banking
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Fertility Clinics
    • 10.5.2. Hospitals
    • 10.5.3. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Technology
    • 10.7.2. By Procedure
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Assisted Reproductive Technology Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Technology, 2017-2031
    • 11.3.1. In Vitro Fertilization
      • 11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 11.3.2. Artificial Insemination
      • 11.3.2.1. Intrauterine Insemination (IUI)
      • 11.3.2.2. Intracervical Insemination (ICI)
      • 11.3.2.3. Others
    • 11.3.3. Surrogacy
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Procedure, 2017-2031
    • 11.4.1. Frozen Donor
    • 11.4.2. Frozen Non-donor
    • 11.4.3. Fresh Donor
    • 11.4.4. Fresh Non-donor
    • 11.4.5. Embryo Banking
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Fertility Clinics
    • 11.5.2. Hospitals
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Technology
    • 11.7.2. By Procedure
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. In Vitro Fertilization
      • 12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 12.3.2. Artificial Insemination
      • 12.3.2.1. Intrauterine Insemination (IUI)
      • 12.3.2.2. Intracervical Insemination (ICI)
      • 12.3.2.3. Others
    • 12.3.3. Surrogacy
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Procedure, 2017-2031
    • 12.4.1. Frozen Donor
    • 12.4.2. Frozen Non-donor
    • 12.4.3. Fresh Donor
    • 12.4.4. Fresh Non-donor
    • 12.4.5. Embryo Banking
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Fertility Clinics
    • 12.5.2. Hospitals
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Technology
    • 12.7.2. By Procedure
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Assisted Reproductive Technology Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. In Vitro Fertilization
      • 13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 13.3.2. Artificial Insemination
      • 13.3.2.1. Intrauterine Insemination (IUI)
      • 13.3.2.2. Intracervical Insemination (ICI)
      • 13.3.2.3. Others
    • 13.3.3. Surrogacy
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Procedure, 2017-2031
    • 13.4.1. Frozen Donor
    • 13.4.2. Frozen Non-donor
    • 13.4.3. Fresh Donor
    • 13.4.4. Fresh Non-donor
    • 13.4.5. Embryo Banking
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Fertility Clinics
    • 13.5.2. Hospitals
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Technology
    • 13.7.2. By Procedure
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. In Vitro Fertilization
      • 14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 14.3.2. Artificial Insemination
      • 14.3.2.1. Intrauterine Insemination (IUI)
      • 14.3.2.2. Intracervical Insemination (ICI)
      • 14.3.2.3. Others
    • 14.3.3. Surrogacy
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Procedure, 2017-2031
    • 14.4.1. Frozen Donor
    • 14.4.2. Frozen Non-donor
    • 14.4.3. Fresh Donor
    • 14.4.4. Fresh Non-donor
    • 14.4.5. Embryo Banking
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Fertility Clinics
    • 14.5.2. Hospitals
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Technology
    • 14.7.2. By Procedure
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. CooperSurgical, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. FUJIFILM Irvine Scientific
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Vitrolife AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Hamilton Thorne, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Nikon Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Nidacon International AB
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Laboratoire CCD
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Esco Micro Pte. Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Technology Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
  • Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022
  • Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022
  • Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022
  • Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022
  • Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022
  • Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022
  • Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031